Therapeuticsmd, Inc.

TXMD·NASDAQ·$2.11Share Price as of 11/2·$24MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/12/26 10-K/AFY 202504/01/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/12/25

Disclosures

8-KCurrent report08/11/26 8-KCurrent report05/12/26 8-KCurrent report03/30/26 8-KCurrent report01/21/26 8-KCurrent report12/16/25

Prospectuses and Registrations

POS AMPost-effective amendment03/24/22 POSASRProspectus / registration03/23/22 S-8Registration of securities for employees10/15/21 S-8Registration of securities for employees08/31/21 S-8Registration of securities for employees06/08/21

Proxies

DEF 14ADefinitive proxy11/03/25 DEFA14AAdditional proxy materials11/03/25 PRE 14APreliminary proxy10/24/25 DEF 14ADefinitive proxy10/25/24 DEFA14AAdditional proxy materials10/25/24

Ownership

SC 13G/ABeneficial ownership (amended)08/05/26 SC 13GBeneficial ownership04/06/26 Form 4Insider transaction12/29/25 Form 4Insider transaction11/05/25 Form 4Insider transaction11/05/25

Other

NT 10-KLate filing notification (10-K)04/01/26 ARSAnnual report to shareholders11/03/25 ARSAnnual report to shareholders10/25/24 AWWithdrawal request06/14/24 DD07/11/23